SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950170-24-025088
Filing Date
2024-03-05
Accepted
2024-03-04 18:14:09
Documents
100
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A inva-20231231.htm   iXBRL 10-K/A 3162226
2 EX-23.1 inva-ex23_1.htm EX-23.1 2539
3 EX-31.1 inva-ex31_1.htm EX-31.1 13665
4 EX-31.2 inva-ex31_2.htm EX-31.2 13004
5 EX-32 inva-ex32.htm EX-32 14271
  Complete submission text file 0000950170-24-025088.txt   17271529

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT inva-20231231.xsd EX-101.SCH 2728081
102 EXTRACTED XBRL INSTANCE DOCUMENT inva-20231231_htm.xml XML 3561759
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-30319 | Film No.: 24717025
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)